Form 4: PROCEPT BioRobotics CFO Executes Sell-to-Cover Transaction

EVP and CFO Kevin Waters sold 357 shares of PROCEPT BioRobotics common stock to satisfy tax withholding obligations.

Summary

• Kevin Waters, EVP and CFO of PROCEPT BioRobotics, sold 357 shares of common stock.
• The transaction occurred on June 8, 2026, at a price of $28.479 per share.
• The sale was conducted to cover tax withholding obligations related to the vesting of Restricted Stock Units (RSUs) on June 5, 2026.
• Following this transaction, the reporting person maintains beneficial ownership of 151,201 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it is a mandatory administrative action related to tax obligations rather than a discretionary investment decision.

Positives

• The transaction was a routine sell-to-cover event rather than a discretionary market sale, indicating no change in long-term confidence.

Negatives

• Reduction in the reporting person's direct equity stake in the company.

Risks

• None identified; this is a standard administrative tax-related transaction.

Future Outlook

No forward-looking guidance provided in this filing.

Industry Context

StockSavvy.ai notes that sell-to-cover transactions are standard practice for executives receiving equity compensation and do not typically signal a change in corporate strategy or management sentiment regarding the company's future performance.

Comparison to Industry Standards

• The transaction aligns with standard corporate governance practices for executive compensation tax management.

Stakeholder Impact

• Minimal impact on shareholders as the sale was limited in volume and purpose-driven.

Key Dates

Keywords

PROCEPT BioRobotics, PRCT, Insider Trading, Form 4, CFO, Equity Compensation